Rocavorexant clinical trials
Also written INDV-2000 and C4X_3256.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2020
How each study uses rocavorexant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses rocavorexant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use DisorderCompletedPhase 2Indivior Inc.NCT06384157Written as INDV-2000How we know
- Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use DisorderCompletedPhase 1Indivior Inc.NCT04976855Written as INDV-2000How we know
- Study of Potential CYP3A4 Induction by INDV-2000 in Healthy AdultsCompletedPhase 1Indivior Inc.NCT05694533Written as INDV-2000How we know
- INDV-2000 First in HumanCompletedPhase 1Indivior Inc.NCT04413552Written as INDV-2000How we know
Codes
What other systems call rocavorexant · ClinicalTrials.gg INT015712
- UNII (FDA) 8RJN30TJM6ROCAVOREXANTOne source FDA
- NCI Thesaurus C216055RocavorexantOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 8RJN30TJM6 | ROCAVOREXANT | One source FDA |
| NCI Thesaurus | C216055 | Rocavorexant | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.